FDA limits use of Johnson & Johnson’s Covid-19 vaccine, citing clotting risk

(By Helen Branswell for STAT)

The Food and Drug Administration on Thursday announced it was limiting access to Johnson & Johnson’s Covid-19 vaccine because of the risk of a blood clotting disorder that was discovered weeks after the vaccine was first put into use in the spring of 2021. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org